Drug discovery, ever a challenge, can be likened to a tall structure. The upper stories rely on the stability of the floors below…

It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work — for…

The vast majority of compounds that enter clinical trials fail to make it through. The result: few drugs, plenty of bills. The consensus…

With the rise of next-generation sequencing and the increase of big data, scientists have gained a deeper understanding of various diseases. So it…

The key to fighting chronic diseases is connecting the multitude of scientific and technological advances to diagnostics and therapeutics. Experts have recognized that…